Breaking News Instant updates and real-time market news.

GSK

GlaxoSmithKline

$42.26

0.68 (1.64%)

12:34
09/03/19
09/03
12:34
09/03/19
12:34

Societe Generale double upgrades GlaxoSmithKline to Buy

As previously reported, Societe Generale analyst Justin Smith upgraded GlaxoSmithKline to Buy from Sell in a research note titled 'An intriguing metamorphosis.' The analyst said he waited to upgrade the stock, despite liking "all the management and capital allocation changes" that new CEO Emma Walmsley has made in her first two years in charge, because he wanted to see "clear evidence of improving innovation" with GlaxoSmithKline's Pharma business. Smith now sees five high profile assets in Phase 3 that will release results in the next 3-4 years, giving improved pipeline visibility, and leaving the analyst forecasting "above-average sales growth from 2023."

  • 09

    Sep

  • 18

    Sep

  • 27

    Sep

  • 02

    Oct

GSK GlaxoSmithKline
$42.26

0.68 (1.64%)

07/17/19
RAJA
07/17/19
NO CHANGE
RAJA
Investors shouldn't overreact to drug proposal headlines, says Raymond James
Raymond James analyst Chris Meekins noted that President Donald Trump has indicated an Executive Order on drug pricing is coming soon, but he believes investors "should be cautious not to overreact" to drug related proposal headlines as he "cannot think of a single proposal that was finalized and also survived a court challenge resulting in a negative impact on earnings" yet from the Trump Administration. Given the history of the current White House to date, Meekins said he is increasingly skeptical the Administration will get anything meaningful finalized and overcome legal challenges that will impact drugmakers' earnings before the 2020 election, he tells investors in a healthcare policy note. Publicly traded large cap drugmakers include AstraZeneca (AZN), Bristol-Myers (BMY), Eli Lilly (LLY), GlaxoSmithKline (GSK), Johnson & Johnson (JNJ), Merck (MRK), Novartis (NVS), Pfizer (PFE), Roche (RHHBY) and Sanofi (SNY).
07/24/19
MSCO
07/24/19
NO CHANGE
MSCO
Warming could create need for up to $125B more vaccinations, says Morgan Stanley
Morgan Stanley analysts led by Matthew Harrison offered a report sizing the impact on biopharma from climate change. They conclude that warmer temperatures are likely to create more hospitable environments for disease transmission and they cite recent research that suggests 385M-725M more people than today may be exposed to infectious diseases such as dengue, Zika, chickungunya, and yellow fever by 2050. They estimate $50B-$125B of incremental vaccinations may be needed, but see the potential for that figure to be as high as $200B with branded pricing of more complicated vaccines. The companies best positioned to benefit from a rising need for infectious disease vaccines include Sanofi (SNY), GlaxoSmithKline (GSK), Moderna (MRNA), Merck (MRK), Johnson & Johnson's (JNJ) Janssen, Pfizer (PFE) and Takeda (TAK), according to Harrison and the team.
08/13/19
JPMS
08/13/19
INITIATION
JPMS
Neutral
GlaxoSmithKline reinstated with a Neutral at JPMorgan
JPMorgan analyst James Gordon reinstated coverage of GlaxoSmithKline with a Neutral rating and 1,700p price target. The analyst sees the stock near-term being Brexit and currency moves.
09/03/19
SOCG
09/03/19
UPGRADE
SOCG
Buy
GlaxoSmithKline upgraded to Buy from Sell at Societe Generale

TODAY'S FREE FLY STORIES

WP

Worldpay

$0.00

(0.00%)

, GPN

Global Payments

$163.80

-0.09 (-0.05%)

15:46
09/18/19
09/18
15:46
09/18/19
15:46
Conference/Events
Wedbush payments/IT services analyst to hold an analyst/industry conference call »

Payments/IT Services…

WP

Worldpay

$0.00

(0.00%)

GPN

Global Payments

$163.80

-0.09 (-0.05%)

FDC

First Data

$0.00

(0.00%)

TSS

TSYS

$132.86

(0.00%)

SQ

Square

$59.56

-0.05 (-0.08%)

PPL

PPL Corp.

$31.21

0.09 (0.29%)

MA

MasterCard

$273.32

-2.93 (-1.06%)

V

Visa

$174.58

-1.8 (-1.02%)

ADS

Alliance Data

$130.61

-0.69 (-0.53%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Sep

  • 23

    Sep

  • 24

    Sep

  • 27

    Oct

  • 06

    Nov

  • 10

    Nov

  • 10

    Nov

  • 13

    Nov

EMCI

EMC Insurance

$35.99

0.01 (0.03%)

15:45
09/18/19
09/18
15:45
09/18/19
15:45
Hot Stocks
EMC Insurance shareholders approve transaction with Employers Mutual Casualty »

EMC Insurance Group…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Sep

15:45
09/18/19
09/18
15:45
09/18/19
15:45
General news
Chair Powell has concluded his presser »

Chair Powell has…

15:40
09/18/19
09/18
15:40
09/18/19
15:40
General news
Treasury Market Summary »

Treasury Market Summary:…

15:39
09/18/19
09/18
15:39
09/18/19
15:39
Conference/Events
UBS U.S. chief economist to hold an analyst/industry conference call »

Head of U.S. Economics…

DDAIF

Daimler AG

$0.00

(0.00%)

15:29
09/18/19
09/18
15:29
09/18/19
15:29
Hot Stocks
China's CATL to supply batteries for Daimler electric trucks »

Daimler Trucks &…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DVN

Devon Energy

$26.30

-0.4 (-1.50%)

15:29
09/18/19
09/18
15:29
09/18/19
15:29
Options
Bullish calendar call spread with a delta hedge in Devon Energy Corp »

Bullish calendar call…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DVN

Devon Energy

$26.32

-0.38 (-1.42%)

15:28
09/18/19
09/18
15:28
09/18/19
15:28
Options
- Bullish calendar call spread with a delta hedge in Devon Energy Corp »

- Bullish calendar call…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UBER

Uber

$34.01

-0.27 (-0.79%)

15:27
09/18/19
09/18
15:27
09/18/19
15:27
Recommendations
Uber analyst commentary  »

Uber London operating…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DXC

DXC Technology

$31.86

-0.51 (-1.58%)

15:25
09/18/19
09/18
15:25
09/18/19
15:25
Options
DXC Technology call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CYRX

Cryoport

$17.69

-0.06 (-0.34%)

15:20
09/18/19
09/18
15:20
09/18/19
15:20
Hot Stocks
Shelton sees Cryoport becoming 'much broader' supply chain company »

Cryoport (CYRX) provides…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MTB

M&T Bank

$158.78

0.66 (0.42%)

15:19
09/18/19
09/18
15:19
09/18/19
15:19
Hot Stocks
M&T Bank lowers prime lending rate to 5.0% from 5.25% »

Effective Thursday,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

15:17
09/18/19
09/18
15:17
09/18/19
15:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

15:16
09/18/19
09/18
15:16
09/18/19
15:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

15:15
09/18/19
09/18
15:15
09/18/19
15:15
General news
On the policy path: »

On the policy path: the…

SPY

SPDR S&P 500 ETF Trust

$299.06

-1.88 (-0.62%)

, SPX

S&P 500

$0.00

(0.00%)

15:11
09/18/19
09/18
15:11
09/18/19
15:11
General news
Fed Chair says not forecasting a recession »

Federal Reserve Chair…

SPY

SPDR S&P 500 ETF Trust

$299.06

-1.88 (-0.62%)

SPX

S&P 500

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPY

SPDR S&P 500 ETF Trust

$299.01

-1.93 (-0.64%)

, SPX

S&P 500

$0.00

(0.00%)

15:07
09/18/19
09/18
15:07
09/18/19
15:07
General news
Breaking General news story on SPDR S&P 500 ETF Trust, S&P 500 »

Powell doesn't think…

SPY

SPDR S&P 500 ETF Trust

$299.01

-1.93 (-0.64%)

SPX

S&P 500

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MTCH

Match Group

$77.00

-2.7 (-3.39%)

, IAC

IAC

$230.15

-6.58 (-2.78%)

15:02
09/18/19
09/18
15:02
09/18/19
15:02
Hot Stocks
Match Group names Thomas Gaissmaier as Chief Human Resources Officer »

Match Group (MTCH)…

MTCH

Match Group

$77.00

-2.7 (-3.39%)

IAC

IAC

$230.15

-6.58 (-2.78%)

FOX

Fox Corp.

$32.24

-0.57 (-1.74%)

DIS

Disney

$135.88

-0.36 (-0.26%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Sep

  • 10

    Oct

  • 24

    Oct

SPY

SPDR S&P 500 ETF Trust

$298.51

-2.43 (-0.81%)

, SPX

S&P 500

$0.00

(0.00%)

15:01
09/18/19
09/18
15:01
09/18/19
15:01
General news
Powell says trade policy among things weighing on outlook »

Fed Chair Powell said the…

SPY

SPDR S&P 500 ETF Trust

$298.51

-2.43 (-0.81%)

SPX

S&P 500

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FRD

Friedman Industries

$6.12

-0.04 (-0.65%)

15:01
09/18/19
09/18
15:01
09/18/19
15:01
Hot Stocks
Friedman Industries names Michael J. Taylor president, CEO »

Friedman Industries…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

15:00
09/18/19
09/18
15:00
09/18/19
15:00
General news
More from Powell: this is a time of difficult judgments and disparate perspectives »

More from Powell: this is…

14:50
09/18/19
09/18
14:50
09/18/19
14:50
General news
Powell in Q&A: on whether this rate cut is still a "mid-cycle adjustment? »

Powell in Q&A: on…

MLHR

Herman Miller

$44.20

-0.3 (-0.67%)

14:49
09/18/19
09/18
14:49
09/18/19
14:49
Options
Herman Miller options imply 12.7% move in share price post-earnings »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

  • 21

    Oct

  • 22

    Oct

CYRX

Cryoport

$17.52

-0.23 (-1.30%)

14:47
09/18/19
09/18
14:47
09/18/19
14:47
Hot Stocks
Shelton sees 'bright future' ahead for Cryoport »

Cryoport (CYRX) provides…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPY

SPDR S&P 500 ETF Trust

$298.64

-2.3 (-0.76%)

, SPX

S&P 500

$0.00

(0.00%)

14:45
09/18/19
09/18
14:45
09/18/19
14:45
General news
Breaking General news story on SPDR S&P 500 ETF Trust, S&P 500 »

Powell says FOMC has…

SPY

SPDR S&P 500 ETF Trust

$298.64

-2.3 (-0.76%)

SPX

S&P 500

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.